Literature DB >> 15688461

Comment on: Assessing surrogates as trial endpoints using mixed models.

Laurence Freedman1.   

Abstract

Mesh:

Year:  2005        PMID: 15688461     DOI: 10.1002/sim.1857

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  3 in total

1.  Surrogate endpoint analysis: an exercise in extrapolation.

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  J Natl Cancer Inst       Date:  2012-12-21       Impact factor: 13.506

2.  Five criteria for using a surrogate endpoint to predict treatment effect based on data from multiple previous trials.

Authors:  Stuart G Baker
Journal:  Stat Med       Date:  2017-11-21       Impact factor: 2.373

3.  Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes.

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  Clin Trials       Date:  2014-11-10       Impact factor: 2.486

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.